Quantitative and sequence-specific analysis of DNA-ligand interaction by means of fluorescent intercalator probes

Journal of Molecular Recognition

Volumn 13, Issue 3, 2000, Pages 157-163

  Kirschstein, Omar ^a   Sip, Miroslav ^b   Kittler, Leonhard ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

Author keywords

bis intercalator; Fluorescence; Minor groove binders; Oligomers; Sequence specific DNA ligand interaction

Indexed keywords

BINDING SITE; CHROMOMYCIN A3; CONGOCIDINE; DNA BINDING MOTIF; DOUBLE STRANDED DNA; FLUORESCENCE; GENETIC COMPLEMENTATION; LIGAND;

BINDING SITES; DNA; DNA PRIMERS; FLUORESCENT DYES; INTERCALATING AGENTS; LIGANDS; NETROPSIN; OLIGONUCLEOTIDES; OLIGOPEPTIDES; OXAZOLES; PYRIDINIUM COMPOUNDS; QUINOLINIUM COMPOUNDS;

EID: 0033935753     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1352(200005/06)13:3<157::AID-JMR498>3.0.CO;2-Y     Document Type: Article

References (41)

1. Allawi HAT, Santa Lucia Jr J. 1998. NMR solution structure of a DNA dodecamer containing single G·T mismatches. Nucleic Acids Res. 26: 4925-4934.
2. Bailly C, Henichart JP. 1991. DNA recognition by intercalator-minor-groove binder hybrid molecules. Bioconing Chem. 2: 379-393.
3. Banville DL, Keniry MA, Kam M, Shafer RH. 1990. NMR studies of the interaction of chromomycinA3 with small DNA duplexes. Binding to GC-containing sequences. Biochemistry 29: 6521-6534.
4. Bell A, Kittler L, Löber G, Zimmer Ch. 1997. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction. J. Mol. Recogn. 10: 245-255.
5. Berman E, Brown SC, James TL, Shafer R. 1985. NMR studies of chromomycin A3 interaction with DNA. Biochemistry 24: 6887-6893.
6. Chan PP, Glazer PM. 1997. Triplex DNA: fundamentals, advances, and potential applications for gene therapy. Mol. Med. 75: 267-282.
7. Chen SM, Leupin W, Rance M, Charin WJ. 1992. Two dimensional NMR studies of d(GGTTATGCGGT)-d(ACCGCATAACC) complex with the minor groove drug SN6999. Biochemistry 31: 4406-4411.
8. Drobyshev AL, Zasedatelev AS, Yersov GM, Mirzabekov AD. 1999. Massive parallel analysis of DNA-Hoechst 33258 binding specificity with a generic oligodeoxyribonucleotide microchip. Nucleic Acids Res. 27: 4100-4105.
9. 2 complex and comparison with X-ray crystal structure. Structure 1: 177-192.
10. Forrow SM, Lee M, Souhami RL, Hartley JA. 1995. The effect of AT and GC sequence specific minor groove-binding agents on restriction endonuclease activity. Chem. Biol. Interact. 96: 125-142.
11. Gottesfeld JM, Neely L, Trauger JW, Baird EE, Dervan PB. 1997. Regulation of gene expression by small molecules. Nature 387: 202-205.
12. Helenè C. 1998. DNA recognition. Reading the minor groove. Nature 391: 436-438.
13. Jacobson JP, Pedersen JB, Hansen LF, Wenner DE. 1995. Site selective bis-intercalation of a homodimeric thiazole orange dye in DNA oligonucleotides. Nucleic Acids Res. 23: 753-760.
14. 2 segments measured by NMR spectroscopy. Nucleic Acids Res. 24: 2911-2918.
15. Kielkopf CL, Baird EE, Dervan PB, Rees D. 1998. Structural basis for GC recognition in the DNA minor groove. Nat. Struct. Biol. 5: 104-109.
16. Kim JL, Nikolov DB, Burley SK. 1993. Co-crystal structure of TBP recognizing the minor groove of a TATA element. Nature 365: 520-527.
17. Kirschstein S, Winter S, Turner D, Löber G. 1999. Detection of the Delta F508 mutation in the CFTR gene by means of time-resolved fluorescence methods. Bioelectrochem. Bioenerg. 48: 415-421.
18. Kittler L, Wähnert U, Baguley BC, Bailly C, Waring MJ, Löber G. 1996. Sequence-specific binding of antitumour bisquaternary ammonium heterocycles to DNA and inhibition of polymerase activity in vitro. Anti-Cancer Drug Des. 11: 101-115.
19. Kittler L, Bell A, Baguley BC, Löber G. 1998. Sequence specific modulation of DNA restriction enzyme cleavage by minor groove binders. Biol. Chem. 379: 519-525.
20. Kittler L, Baguley BC, Löber G, Waring MJ. 1999. Sequence-specific interactions of minor groove binders with restriction fragments of cDNAs for H tau 40 protein and MAP kinase 2. A qualitative and quantitative footprinting study. J. Mol. Recogn. 12: 121-130.
21. Kopka ML, Yoon C, Goodsell D, Pjura P, Dickerson RE. 1985. The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl Acad Sci. USA 82: 1376-1380.
22. Kopka ML, Goodsell DS, Han GW, Chiu TK, Lown JW, Dickerson RE. 1997. Defining GC-specificity in the minor groove: side-by-side binding of the di-imidazole lexitropsin to C-A-T-G-G-C-C-A-T-G. Structure 15: 1033-1046.
23. Lee M, Rhodes AL, Wyott MD, Forrow S, Hartley JA. 1993. GC base sequence recognition by oligo(imidazolecarboxamide) and C-terminus-modified analogues of distamycin deduced from circular dichroism, proton nuclear magnetic resonance, and ethidiumpropylethylenediaminetetraacetate-iron(II) footprinting studies. Biochemistry 32: 4237-4245.
24. Liu C, Chen, FM. 1994. Oligonucleotide studies of sequence-specific binding of chromomycin A3 to DNA. Biochemistry 31: 1419-1424.
25. Lown JW. 1992. Lexitropsins in antiviral drug development. Antiviral Res. 17: 179-196.
26. Maher LJ. 1992. DNA triple-helix formation: an approach to artificial gene repressors? BioEssays 14: 807-815.
27. Popa LM, Winter S, Löber G. 1994. Some new properties of DNA-YOYO-3 homodimer complexes revealed by electrophoresis and fluorescence lifetime measurements. Biochem. Mol. Biol. Int. 34: 1189-1196.
28. Sayers EW, Waring MJ. 1993. Footprinting titration studies on the binding of echinomycin to DNA incapable of forming Hoogsteen base pairs. Biochemistry 32: 9094-9107.
29. Slickers P, Hildebrand M, Kittler L, Löber G, Sühnel J. 1998. Molecular modelling and footprinting studies of DNA minor groove binders: bisquaternary ammonium heterocyclic compounds. Anti-Cancer Drug Des. 13: 463-488.
30. Spielmann HP, Wenner DE, Jacobson JP. 1995. Spin-labeled psoralen probes for the study of DNA dynamics. Biochemistry34: 14801-14814.
31. Stull RA, Szoka FC. 1995. Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects. Pharm. Res. 17: 456-485.
32. Surovaya AN, Burckhardt G, Grokhowsky SL, Birch-Hirschfeld E, Gurski GV, Zimmer Ch. 1997. Hairpin polyamides that use parallel and antiparallel side-by-side peptide motifs in binding to DNA. J. Biomol. Struct. Dyn. 14: 595-606.
33. Uhlmann E, Peyman A. 1990. Antisense oligonucleosides. A new therapeutic principle. Chem. Res. 90: 544-584.
34. Wähnert U, Zimmer Ch. 1986. Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog. Biophys. Mol. Biol. 47: 31-112.
35. Waring MJ. 1981. DNA modification and cancer. Au. Rev. Biochem. 50: 159-192.
36. Wemmer D. 1998. Reading DNA. Nat. Struct. Biol. 5: 169-171.
37. Whitton JL. 1994. Induction of protective immunity using minigenes. Ann. NY Acad. Sci. 15: 107-117.
38. Wilson AD, Jones RL. 1981. Intercalating chemistry. Whittigham M.S. and Jacobson AJ, eds. Academic Press, London.
39. Winter S, Löber G. 1997. DNA-binding and fluorescence properties of the DNA bis-intercalating purple oxazole dimer POPO-I. J. Biomed. Optics. 2: 125-130.
40. Workman P. 1992. New anticancer drug design and discovery based on advances in molecular oncology. Sem. Cancer Biol. 3: 329-333.
41. Zimmer Ch, Wähnert U. 1990. In Landold-Börnstein: Numerical Relationships in Science and Technology. New Series Group VII Vol. 1 (4.7), Springer, Berlin.